{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T16:13:36Z","timestamp":1770567216495,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"crossref","award":["76354"],"award-info":[{"award-number":["76354"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00415-022-11074-2","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:04:35Z","timestamp":1647450275000},"page":"4546-4554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"269","clinical-trial-number":[{"clinical-trial-number":"nct01114321","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Steven","family":"Beze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Durif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-4899","authenticated-orcid":false,"given":"Ana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"11074_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","volume":"289","author":"G F\u00e9nelon","year":"2010","unstructured":"F\u00e9nelon G, Alves G (2010) Epidemiology of psychosis in Parkinson\u2019s disease. J Neurol Sci 289:12\u201317. https:\/\/doi.org\/10.1016\/j.jns.2009.08.014","journal-title":"J Neurol Sci"},{"key":"11074_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09925-x","author":"A Marques","year":"2020","unstructured":"Marques A, Beze S, Pereira B et al (2020) Visual hallucinations and illusions in Parkinson\u2019s disease: the role of ocular pathology. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09925-x","journal-title":"J Neurol"},{"key":"11074_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2021.04.007","author":"A Marques","year":"2021","unstructured":"Marques A, Beze S, Lambert C et al (2021) Psycho-sensory modalities of visual hallucinations and illusions in Parkinson\u2019s disease. Revue Neurologique. https:\/\/doi.org\/10.1016\/j.neurol.2021.04.007","journal-title":"Revue Neurologique"},{"key":"11074_CR4","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212838","author":"A Marques","year":"2021","unstructured":"Marques A, Taylor NL, Roquet D et al (2021) Structural and functional correlates of hallucinations and illusions in Parkinson\u2019s disease. J Parkinsons Dis. https:\/\/doi.org\/10.3233\/JPD-212838","journal-title":"J Parkinsons Dis"},{"key":"11074_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mds.20263","volume":"20","author":"AD de Maindreville","year":"2005","unstructured":"de Maindreville AD, F\u00e9nelon G, Mahieux F (2005) Hallucinations in Parkinson\u2019s disease: a follow-up study. Mov Disord 20:212\u2013217. https:\/\/doi.org\/10.1002\/mds.20263","journal-title":"Mov Disord"},{"key":"11074_CR6","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1212\/wnl.57.11.2078","volume":"57","author":"CG Goetz","year":"2001","unstructured":"Goetz CG, Leurgans S, Pappert EJ et al (2001) Prospective longitudinal assessment of hallucinations in Parkinson\u2019s disease. Neurology 57:2078\u20132082. https:\/\/doi.org\/10.1212\/wnl.57.11.2078","journal-title":"Neurology"},{"key":"11074_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"11074_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"11074_CR9","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/mds.21696","volume":"22","author":"M Visser","year":"2007","unstructured":"Visser M, Verbaan D, van Rooden SM et al (2007) Assessment of psychiatric complications in Parkinson\u2019s disease: the SCOPA-PC. Mov Disord 22:2221\u20132228. https:\/\/doi.org\/10.1002\/mds.21696","journal-title":"Mov Disord"},{"key":"11074_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz CG, Fahn S, Martinez-Martin P et al (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord 22:41\u201347. https:\/\/doi.org\/10.1002\/mds.21198","journal-title":"Mov Disord"},{"key":"11074_CR11","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25:2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"key":"11074_CR12","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1212\/WNL.0000000000009214","volume":"94","author":"CDJM Borm","year":"2020","unstructured":"Borm CDJM, Visser F, Werkmann M et al (2020) Seeing ophthalmologic problems in Parkinson disease: results of a visual impairment questionnaire. Neurology 94:e1539\u2013e1547. https:\/\/doi.org\/10.1212\/WNL.0000000000009214","journal-title":"Neurology"},{"key":"11074_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jnnp-2019-322702","volume":"91","author":"J O\u2019Brien","year":"2020","unstructured":"O\u2019Brien J, Taylor JP, Ballard C et al (2020) Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. J Neurol Neurosurg Psychiatry 91:512\u2013519. https:\/\/doi.org\/10.1136\/jnnp-2019-322702","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11074_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0891988705284739","volume":"19","author":"H Matsui","year":"2006","unstructured":"Matsui H, Udaka F, Tamura A et al (2006) Impaired visual acuity as a risk factor for visual hallucinations in Parkinson\u2019s disease. J Geriatr Psychiatry Neurol 19:36\u201340. https:\/\/doi.org\/10.1177\/0891988705284739","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"11074_CR15","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.jcjo.2018.01.036","volume":"53","author":"CS Smith","year":"2018","unstructured":"Smith CS, Nichols J, Riaz KM (2018) Remission of Charles Bonnet syndrome after cataract extraction. Can J Ophthalmol 53:e221\u2013e222. https:\/\/doi.org\/10.1016\/j.jcjo.2018.01.036","journal-title":"Can J Ophthalmol"},{"key":"11074_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/IMCRJ.S218687","volume":"13","author":"AA Osa","year":"2020","unstructured":"Osa AA, Bowen TJ, Whitson JT (2020) Charles bonnet syndrome in a patient with Parkinson\u2019s disease and bilateral posterior capsule opacification. Int Med Case Rep J 13:7\u201310. https:\/\/doi.org\/10.2147\/IMCRJ.S218687","journal-title":"Int Med Case Rep J"},{"key":"11074_CR17","first-page":"351","volume":"56","author":"H Matsui","year":"2004","unstructured":"Matsui H, Udaka F, Oda M et al (2004) Two cases of Parkinson\u2019s disease in which visual hallucinations disappeared after cataract surgery. No To Shinkei 56:351\u2013354","journal-title":"No To Shinkei"},{"key":"11074_CR18","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/mds.28182","volume":"35","author":"AG Hamedani","year":"2020","unstructured":"Hamedani AG, Abraham DS, Maguire MG, Willis AW (2020) Visual impairment is more common in Parkinson\u2019s disease and is a risk factor for poor health outcomes. Mov Disord 35:1542\u20131549. https:\/\/doi.org\/10.1002\/mds.28182","journal-title":"Mov Disord"},{"key":"11074_CR19","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.ophtha.2014.07.020","volume":"121","author":"FA Sloan","year":"2014","unstructured":"Sloan FA, Yashkin AP, Chen Y (2014) Gaps in receipt of regular eye examinations among medicare beneficiaries diagnosed with diabetes or chronic eye diseases. Ophthalmology 121:2452\u20132460. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.020","journal-title":"Ophthalmology"},{"key":"11074_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","volume":"40","author":"MS Ekker","year":"2017","unstructured":"Ekker MS, Janssen S, Seppi K et al (2017) Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked. Parkinsonism Relat Disord 40:1\u201310. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.014","journal-title":"Parkinsonism Relat Disord"},{"key":"11074_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/jamaophthalmol.2018.5138","volume":"137","author":"BC Stagg","year":"2019","unstructured":"Stagg BC, Ehrlich JR, Choi H, Levine DA (2019) Association of cognitive impairment and dementia with receipt of cataract surgery among community-dwelling medicare beneficiaries. JAMA Ophthalmol 137:114\u2013117. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.5138","journal-title":"JAMA Ophthalmol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11074-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T16:30:08Z","timestamp":1658161808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11074-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11074"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11074-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Steven Beze has nothing to disclose; Lucia Castellani has nothing to disclose; Bruno Pereira has nothing to disclose; Frederic Chiambaretta has nothing to disclose; Franck Durif has nothing to disclose. Ana Marques reports grants from Fondation de France, during the conduct of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The protocol was approved by the\nSouth\u2013West and Overseas II Ethical Committee, France (2017-A02605-48). All patients gave their written informed\nconsent as per the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}